Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-063543
Filing Date
2025-05-05
Accepted
2025-05-05 16:10:21
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmea-20250331.htm   iXBRL 10-Q 2114221
2 EX-10.1 bmea-ex10_1.htm EX-10.1 76853
3 EX-31.1 bmea-ex31_1.htm EX-31.1 18179
4 EX-31.2 bmea-ex31_2.htm EX-31.2 18163
5 EX-32.1 bmea-ex32_1.htm EX-32.1 10105
6 EX-32.2 bmea-ex32_2.htm EX-32.2 10116
7 GRAPHIC img81389725_0.jpg GRAPHIC 108820
  Complete submission text file 0000950170-25-063543.txt   6685941

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bmea-20250331.xsd EX-101.SCH 794178
59 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20250331_htm.xml XML 902131
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40335 | Film No.: 25913026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)